Staatscourant van het Koninkrijk der Nederlanden
Datum publicatie | Organisatie | Jaargang en nummer | Rubriek | Datum ondertekening |
---|---|---|---|---|
Ministerie van Volksgezondheid, Welzijn en Sport | Staatscourant 2018, 55324 | Besluiten van algemene strekking |
Zoals vergunningen, bouwplannen en lokale regelgeving.
Adressen en contactpersonen van overheidsorganisaties.
U bent hier:
Datum publicatie | Organisatie | Jaargang en nummer | Rubriek | Datum ondertekening |
---|---|---|---|---|
Ministerie van Volksgezondheid, Welzijn en Sport | Staatscourant 2018, 55324 | Besluiten van algemene strekking |
De Regeling zorgverzekering wordt gewijzigd als volgt:
A
Bijlage 1 wordt gewijzigd als volgt:
1. In onderdeel A worden de volgende regels opgenomen:
0A07DAAO V |
123064=14220 |
LIVSANE DIARREEREMMER LOPERAMIDE HCL CAPSULE 2MG |
5,00 |
STUK |
0,23143 |
1A07AAAOS V |
119514//6771 |
NYSTATINE EURECO-PHARMA SUSPENSIE 100.000E/ML |
4,00 |
ML |
0,10380 |
0A09AAAO V |
122875//10656 |
CREON CAPSULE MSR (PANCREATINE 150MG) |
6,00 |
STUK |
0,40319 |
0A09AAAO V |
123257//13760 |
PANZYTRAT 25000 CAPSULE MSR |
2,40 |
STUK |
1,00796 |
0A10BXAP V |
EU/1/17/1251/002 |
OZEMPIC 0,25 INJVST 1,34MG/ML PEN 1,5ML+TOEB START |
0,05 |
ML |
92,07714 |
0A10BXAP V |
EU/1/17/1251/003 |
OZEMPIC 0,5 INJVLST 1,34MG/ML PEN 1,5ML + TOEBEH |
0,05 |
ML |
92,07714 |
0A10BXAP V |
EU/1/17/1251/005 |
OZEMPIC 1 INJVLST 1,34MG/ML PEN 3ML + TOEBEH |
0,05 |
ML |
92,07714 |
0B02AAAO V |
123211//5574 |
CYKLOKAPRON TABLET FILMOMHULD 500MG |
4,00 |
STUK |
0,36266 |
0B02AAAP V |
120103 |
TRANEXAMINEZUUR MYLAN INJVLST 100MG/ML AMPUL 5ML |
20,00 |
ML |
0,78722 |
0C07ABAO V |
118136 |
METOPROLOLTARTRAAT AUROBINDO TABLET FILMOMH 100MG |
1,50 |
STUK |
0,27075 |
0C07ABAO V |
119978 |
NEBIVOLOL AUROBINDO TABLET 5MG |
1,00 |
STUK |
0,40613 |
0C08CAAO V |
123369//25285 |
VASEXTEN CAPSULE MGA 10MG |
1,00 |
STUK |
0,65450 |
YC09BXAO V |
123114//112145 |
TRIPLIXAM TABLET FILMOMHULD 5/1,25/ 5MG |
1,00 |
STUK |
1,43633 |
YC09BXAO V |
123110//112147 |
TRIPLIXAM TABLET FILMOMHULD 10/2,5/ 5MG |
1,00 |
STUK |
2,21816 |
YC09BXAO V |
123115//112148 |
TRIPLIXAM TABLET FILMOMHULD 10/2,5/10MG |
1,00 |
STUK |
2,87266 |
YC09DBBO V |
119939 |
OLMESARTANMEDOXOMIL/AMLODIPINE ACC TAB FO 20/5MG |
1,00 |
STUK |
1,39870 |
YC09DBBO V |
119942 |
OLMESARTANMEDOXOMIL/AMLODIPINE ACC TAB FO 40/10MG |
1,00 |
STUK |
2,79741 |
YC09DBBO V |
119941 |
OLMESARTANMEDOXOMIL/AMLODIPINE ACC TAB FO 40/5MG |
1,00 |
STUK |
2,14290 |
0C10AAAO V |
122032 |
ATORVASTATINE FOCUS CARE TABLET FILMOMHULD 10MG |
2,00 |
STUK |
0,83042 |
0C10ACAO V |
118956 |
EZETIMIBE MEDICAL VALLEY TABLET 10MG |
1,00 |
STUK |
1,72101 |
YC10AXAO V |
121918//114375 |
ATOZET TABLET 10/40MG |
1,00 |
STUK |
4,48907 |
YC10AXAO V |
122544//30929 |
INEGY TABLET 10/40MG |
1,00 |
STUK |
3,56638 |
0D07ACADL V |
122755//14332 |
ELOCON LOTION 1MG/G |
1,00 |
ML |
0,15333 |
0G02BAAV V |
123274//118462 |
KYLEENA I.U.D. |
1,00 |
STUK |
121,15930 |
0G02CBAO V |
123401//15375 |
DOSTINEX TABLET 0,5MG |
0,10 |
STUK |
7,96341 |
0G03AABO V |
118994 |
ORNIBEL RING VAGINAAL |
0,04 |
STUK |
2,78318 |
0G03ACBO V |
111892 |
LEVONORGESTREL FOCUS TABLET 1,5MG |
1,00 |
STUK |
5,32280 |
0G03CAAO V |
122678//19258 |
SYSTEN 75 PLEISTER MGA 75MCG/24UUR |
0,19 |
STUK |
0,98229 |
0G03CAAO V |
122679//19259 |
SYSTEN 100 PLEISTER MGA 100MCG/24UUR |
0,14 |
STUK |
1,30973 |
YG04CAAO V |
122665//104130 |
COMBODART CAPSULE 0,5/0,4MG |
1,00 |
STUK |
2,08572 |
YG04CAAO V |
123255//104130 |
COMBODART CAPSULE 0,5/0,4MG |
1,00 |
STUK |
2,08572 |
YG04CAAO V |
123366//104130 |
COMBODART CAPSULE 0,5/0,4MG |
1,00 |
STUK |
2,08572 |
0H01CBAP V |
122791//18237 |
SANDOSTATINE LAR INJPDR FL 30MG + SOLV 2ML |
0,02 |
STUK |
1633,60875 |
0J07BCAP V |
122990//17316 |
ENGERIX-B VACCIN 20MCG/ML WWSP 1ML |
1,00 |
ML |
29,51840 |
0L02AEADI V |
123337//12450 |
DECAPEPTYL CR INJPDR 3,75MG IN WWSP +SOLV 1ML |
1,00 |
STUK |
184,07590 |
0N02CCAO V |
121161//27212 |
FROMIREX TABLET OMHULD 2,5MG |
1,00 |
STUK |
6,21227 |
0N03AXCO V |
EU/1/15/1011/072 |
PREGABALINE SANDOZ CAPSULE 300MG |
1,00 |
STUK |
3,92066 |
4N05AXAO V |
121621 |
PALIPERIDON SANDOZ RETARD TABLET MVA 3MG |
2,00 |
STUK |
2,37781 |
4N05AXAO V |
121622 |
PALIPERIDON SANDOZ RETARD TABLET MVA 6MG |
1,00 |
STUK |
3,96302 |
4N05AXAO V |
121623 |
PALIPERIDON SANDOZ RETARD TABLET MVA 9MG |
0,67 |
STUK |
5,94453 |
0N06AAAO V |
116782 |
NORTRIPTYLINE MILSTEIN TABLET 50MG |
1,50 |
STUK |
0,29485 |
0N06BAAO V |
122872//33227 |
EQUASYM XL CAPSULE MGA 10MG |
3,00 |
STUK |
0,12116 |
0N06BAAO V |
122873//33228 |
EQUASYM XL CAPSULE MGA 20MG |
1,50 |
STUK |
0,24232 |
0N06BAAO V |
122870//33229 |
EQUASYM XL CAPSULE MGA 30MG |
1,00 |
STUK |
0,36348 |
0N06BAAO V |
122869//111228 |
EQUASYM XL CAPSULE MGA 40MG |
0,75 |
STUK |
0,48464 |
YR01ADAN V |
123321//114215 |
DYMISTA NEUSSPRAY 137/50MCG/DO FLACON 120DO |
1,00 |
DO |
0,17688 |
0R03ACCIDCV |
123208//18150 |
SEREVENT DISKUS INHPDR 50MCG 60DO |
2,00 |
DO |
0,61011 |
0R03BABID V |
123307//31633 |
ALVESCO 160 AEROSOL 160MCG/DO |
1,00 |
DO |
0,70100 |
0R03BABID V |
123411//31633 |
ALVESCO 160 AEROSOL 160MCG/DO SPBS 60DO + INH |
1,00 |
DO |
0,70100 |
0R03BADID V |
123317//18195 |
FLIXOTIDE DISKUS INHPDR 500MCG 60DO |
1,20 |
DO |
0,59385 |
0R03BADID V |
122923//110255 |
QVAR 100 EFA REDIHALER 100MCG/DO SPBS 200DO |
4,00 |
DO |
0,17815 |
YR03AKAIDAV |
123399//116348 |
SYMBICORT AEROSOL 200/6MCG/DOSIS SPUITBUS 120DO |
1,00 |
DO |
0,40611 |
YR03AKAIDCV |
123412//25887 |
SYMBICORT TURBUHALER INHALPDR 200/6MCG/DO 120DO |
1,00 |
DO |
0,48321 |
2R06AXAO K |
123258//33414 |
XYZAL DRANK 0,5MG/ML |
10,00 |
ML |
0,09461 |
2R06AXAO V |
123205//21625 |
TELFAST TABLET OMHULD 180MG |
0,67 |
STUK |
0,75748 |
0S01AABZ V |
121925//10225 |
TOBREX OOGZALF TUBE 3,5G |
0,28 |
GRAM |
0,22624 |
0S01EEAG V |
122004 |
SAFLUTAN 15 MCG/ML OOGDRUPPELS. OPLOSSING |
0,10 |
ML |
8,52667 |
0S01EEAG V |
123264//103823 |
SAFLUTAN OOGDRUPPELS 15MCG/ML FLACON 0,3ML |
1,00 |
STUK |
0,85267 |
2. In onderdeel A worden de volgende regels vervangen door de daarbij vermelde teksten:
‘0C02ABAO V |
10647 |
METHYLDOPA (L) PCH TABLET 125MG |
8,00 |
STUK |
0,06730 |
‘: |
0C02ABAO V |
10647 |
METHYLDOPA (L) TEVA TABLET 125MG |
8,00 |
STUK |
0,06730 |
; |
‘0C08DAAO V |
14495 |
VERAPAMIL HCL PCH DRAGEE 120MG |
3,33 |
STUK |
0,15642 |
‘: |
0C08DAAO V |
14495 |
VERAPAMIL HCL TEVA DRAGEE 120MG |
3,33 |
STUK |
0,15642 |
; |
‘YC09DBBO V |
119893 |
OLMESARTAN MEDOXOMIL/AMLODIPINE TEVA TB FO 20/5MG |
1,00 |
STUK |
1,39870 |
’: |
YC09DBBO V |
119893 |
OLMESARTANMEDOXOMIL/AMLODIPINE TEVA TAB FO 20/5MG |
1,00 |
STUK |
1,39870 |
; |
‘YC09DBBO V |
119897 |
OLMESARTAN MEDOXOMIL/AMLODIPINE TEVA TB FO 40/10MG |
1,00 |
STUK |
2,79741 |
’: |
YC09DBBO V |
119897 |
OLMESARTANMEDOXOMIL/AMLODIPINE TEVA TAB FO 40/10MG |
1,00 |
STUK |
2,79741 |
; |
‘YC09DBBO V |
119896 |
OLMESARTAN MEDOXOMIL/AMLODIPINE TEVA TB FO 40/5MG |
1,00 |
STUK |
2,14290 |
’: |
YC09DBBO V |
119896 |
OLMESARTANMEDOXOMIL/AMLODIPINE TEVA TAB FO 40/5MG |
1,00 |
STUK |
2,14290 |
; |
‘0N03AXAO V |
29712 |
LAMOTRIGINE PCH DISPERS TABLET 200MG |
1,50 |
STUK |
2,93253 |
’: |
0N03AXAO V |
29712 |
LAMOTRIGINE TEVA DISPERS TABLET 200MG |
1,50 |
STUK |
2,93253 |
; |
‘4N05AXAO V |
EU1/17/1209/001 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/001 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/002 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/002 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/003 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/003 |
REAGILA CAPSULE 1,5MG |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/004 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/004 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/005 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/005 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/006 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/006 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/007 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/007 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/008 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/008 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/009 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/009 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/010 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
’: |
4N05AXAO V |
EU/1/17/1209/010 |
REAGILA 1,5 MG HARDE CAPSULE |
2,00 |
STUK |
2,37781 |
; |
‘4N05AXAO V |
EU1/17/1209/011 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/011 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/012 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/012 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/013 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/013 |
REAGILA CAPSULE 3MG |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/014 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/014 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/015 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/015 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/016 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/016 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/017 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/017 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/018 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/018 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/019 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/019 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/020 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
’: |
4N05AXAO V |
EU/1/17/1209/020 |
REAGILA 3 MG HARDE CAPSULE |
1,00 |
STUK |
3,96302 |
; |
‘4N05AXAO V |
EU1/17/1209/021 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/021 |
REAGILA CAPSULE 4,5MG |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/022 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/022 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/023 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/023 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/024 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/024 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/025 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/025 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/026 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/026 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/027 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/027 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/028 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
’: |
4N05AXAO V |
EU/1/17/1209/028 |
REAGILA 4,5 MG HARDE CAPSULE |
0,67 |
STUK |
5,94453 |
; |
‘4N05AXAO V |
EU1/17/1209/029 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/029 |
REAGILA CAPSULE 6MG |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/030 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/030 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/031 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/031 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/032 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/032 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/033 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/033 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/034 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/034 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/035 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/035 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
; |
‘4N05AXAO V |
EU1/17/1209/036 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
’: |
4N05AXAO V |
EU/1/17/1209/036 |
REAGILA 6 MG HARDE CAPSULE |
0,50 |
STUK |
7,92603 |
3. In onderdeel B worden de volgende regels opgenomen:
123336//118889 |
ACARIZAX LYOPHILISAAT V ORAAL GEBRUIK 12 SQ-HDM |
EU/1/18/1289/001 |
BIKTARVY TABLET FILMOMHULD |
122072//7824 |
CITANEST/OCTAPRESSINE INJ 30MG/0,54MCG/ML CIL1,8ML |
122900//33660 |
COSOPT CONSERVEERMIDDELVRIJ OOGDRUPPELS FLAC 0,2ML |
123159//15437 |
ESKAZOLE TABLET 400MG |
123367//8426 |
LONNOTEN TABLET 10MG |
115126 |
RITONAVIR ACCORD TABLET FILMOMHULD 100MG |
119096 |
TENOFOVIRDISOPROXIL AUROBINDO TABL FILMOMH 245MG |
EU/1/17/1224/001 |
XERMELO TABLET FILMOMHULD 250MG |
EU/1/17/1224/002 |
XERMELO 250 MG FILMOMHULDE TABLETTEN |
123207//28113 |
ZALDIAR TABLET FILMOMHULD |
B
In bijlage 2 komt de aanhef van onderdeel 85 te luiden:
85. Lixisenatide, dulaglutide en semaglutide
Deze regeling treedt in werking met ingang van 1 oktober 2018. Indien de Staatscourant waarin deze regeling wordt geplaatst, wordt uitgegeven na 30 september 2018, treedt zij in werking met ingang van de dag na de datum van uitgifte van de Staatscourant waarin zij wordt geplaatst en werkt terug tot en met 1 oktober 2018.
Kopieer de link naar uw clipboard
https://zoek.officielebekendmakingen.nl/stcrt-2018-55324.html
De hier aangeboden pdf-bestanden van het Staatsblad, Staatscourant, Tractatenblad, provinciaal blad, gemeenteblad, waterschapsblad en blad gemeenschappelijke regeling vormen de formele bekendmakingen in de zin van de Bekendmakingswet en de Rijkswet goedkeuring en bekendmaking verdragen voor zover ze na 1 juli 2009 zijn uitgegeven. Voor pdf-publicaties van vóór deze datum geldt dat alleen de in papieren vorm uitgegeven bladen formele status hebben; de hier aangeboden elektronische versies daarvan worden bij wijze van service aangeboden.